Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-27
2007-02-27
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S340000, C514S363000, C514S364000, C514S365000, C548S214000, C548S136000, C548S143000, C548S146000, C548S202000, C546S268700, C546S269400, C546S269700, C546S271100
Reexamination Certificate
active
10982586
ABSTRACT:
Compounds of formula I:inhibit gamma-secretase and hence find use in treatment of Alzheimer's disease.
REFERENCES:
patent: WO 01/70677 (2001-09-01), None
patent: WO 02/36555 (2002-05-01), None
Pangalos et al. Biochemical Society Transactions vol. 33, part 4, pp. 553-558.
Churcher et al. Current Pharmaceutical Design, 2005, 11, 3363-3382.
Castro Pineiro Jose Luis
Collins Ian James
Harrison Timothy
Habte Kahsay
Merck Sharp & Dohme Limited
Todaro John C.
Winokur Melvin
LandOfFree
Gamma-secretase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-secretase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-secretase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888492